Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 16;9(3):3741-3751.
doi: 10.18632/oncotarget.23345. eCollection 2018 Jan 9.

Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI

Affiliations

Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI

Yong Wang et al. Oncotarget. .

Abstract

To explore therapeutic effect of nerve growth factor (NGF) on cerebral infarction by establishing canine middle cerebral artery occlusion (MCAO) infarct model. The magnetic resonance imaging (MRI) technology was used to study effects of NGF on cerebral infarction, and the results of MRI indexes (such as diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI)) were compared with the results of pathology, cell biology and molecular biology. The clinical manifestations of the canine infarction model treated by NGF were significantly improved within 7 days compared with control group. The therapeutic evaluation of NGF effect could be determine by canine cerebral infarction treated by NGF within 6 hours according to DWI and PWI. From 6 hours to 7 days, therapeutic evaluation of NGF could be determine by T1WI, T2WI and FLAIR. DWI and PWI could find the change of cerebral ischemia at the early stage, provide advantages for qualitative diagnosis of early-stage cerebral infarction and observation of efficacy in early treatment, initially showing that their great potential for NGF role on cerebral ischemia and mechanism.

Keywords: canine middle cerebral artery occlusion; diffusion-weighted imaging; magnetic resonance imaging; nerve growth factor; perfusion-weighted imaging.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors report no relationships that could be construed as a conflict of interest.

Figures

Figure 1
Figure 1
The normal images of T2WI (A), FLAIR (B), T1WI (C) and DWI (D) from the same slice of canines’ brain.
Figure 2
Figure 2
(A) 24 hours after cerebral ischemia, some microressels could be discerned on surface of cortex at the site of lesion; (B) 24 hours after cerebral ischemia, some lesion could be discerned on cortex.
Figure 3
Figure 3
(A) Comparison of the number of involved neurons in per view (HE staining × 400) among different group. (B) Comparison of the number of involved neuron synapses in per view (Electron Microscope × 4000) among different group.
Figure 4
Figure 4
(A) 6 hours after stroke, mitochondrion edema was seen (×20000) from different views; (B) 24 hours after stroke, mitochondrion edema was severe, the number of lipofascin paoticles were decreased (×20000) from different views.
Figure 5
Figure 5. Immunohistochemistry for NGF of canines’ brain
(A) The number of positive cells was increased gradually, and the degree of straining also was increased gradually; (B) The counts and degree of straining were more in those treated canine from group D (NGF treatment for 3 months).

Similar articles

References

    1. Tan XL, Xue YQ, Ma T, Wang X, Li JJ, Lan L, Malik KU, McDonald MP, Dopico AM, Liao FF. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener. 2015;24:10–24. - PMC - PubMed
    1. Wang K, Zhang D, Wu J, Liu S, Zhang X, Zhang B. A comparative study of Danhong injection and Salvia miltiorrhiza injection in the treatment of cerebral infarction: A systematic review and meta-analysis. Medicine. 2017;96:e7079. - PMC - PubMed
    1. Wang Z, Xia Y, Zhao Y, Chen L, Zhu Y. Intestinal gutsfeature and role of apoE and glucose metabolism in cerebral infarction patients. Int J Clin Exp Pathol. 2017;10:561–565.
    1. Cuello AC. Nerve Growth Factor. Encyclopedia of Psychopharmacology. 2015:1–9.
    1. Zhao HM, Liu XF, Mao XW, Chen CF. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction. Chin Med Sci J. 2004;19:257–261. - PubMed

LinkOut - more resources